(Q46249734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

non-alcoholic fatty liver

17 January 2020

main subject

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Daniel Antonio de Luis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

O Izaola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Gonzalez Sagrado

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R Conde

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M C Velasco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Alvarez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Pacheco

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

J M González

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

14 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1772-1777

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19005759%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-008-0539-9

17 January 2020

exact match

0 references

cites work

Standards of medical care in diabetes--2007.

1 reference

12 December 2020

Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.

1 reference

12 December 2020

Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic parameters in subjects with and without diabetes: a cross-sectional study.

1 reference

12 December 2020

Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes

1 reference

12 December 2020

Pathologic assessment of non-alcoholic fatty liver disease

1 reference

12 December 2020

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

1 reference

12 December 2020

Visfatin: a putative biomarker for metabolic syndrome is not influenced by pioglitazone or simvastatin treatment in nondiabetic patients at cardiovascular risk -- results from the PIOSTAT study

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Nonalcoholic steatohepatitis: definition and pathology

1 reference

12 December 2020

Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance

1 reference

12 December 2020

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

1 reference

12 December 2020

Interleukin-6 is a key mediator of the hepatoprotective and pro-proliferative effects of ischaemic preconditioning in mice

1 reference

12 December 2020

Visfatin: the missing link between intra-abdominal obesity and diabetes?

1 reference

12 December 2020

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

1 reference

12 December 2020

Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients

1 reference

12 December 2020

Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

1 reference

12 December 2020

IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver.

1 reference

12 December 2020

Molecular mediators of hepatic steatosis and liver injury

1 reference

12 December 2020

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

12 December 2020